Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. reduced its position in Omnicell, Inc. (NASDAQ:OMCL) by 48.9% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 231,825 shares of the company’s stock after selling 221,883 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Omnicell were worth $10,316,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. Geode Capital Management LLC boosted its stake in shares of Omnicell by 0.3% in the third quarter. Geode Capital Management LLC now owns 1,104,745 shares of the company’s stock valued at $48,176,000 after buying an additional 2,877 shares in the last quarter. Shaker Investments LLC OH purchased a new stake in shares of Omnicell during the 4th quarter worth $550,000. Empowered Funds LLC acquired a new position in shares of Omnicell during the 4th quarter worth $388,000. Exchange Traded Concepts LLC increased its holdings in shares of Omnicell by 6.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 319,682 shares of the company’s stock valued at $14,232,000 after purchasing an additional 20,031 shares in the last quarter. Finally, SG Americas Securities LLC lifted its stake in shares of Omnicell by 56.5% in the fourth quarter. SG Americas Securities LLC now owns 39,359 shares of the company’s stock valued at $1,752,000 after purchasing an additional 14,202 shares during the period. Hedge funds and other institutional investors own 97.70% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on OMCL. StockNews.com raised shares of Omnicell from a “hold” rating to a “buy” rating in a report on Tuesday. JPMorgan Chase & Co. dropped their price objective on Omnicell from $44.00 to $36.00 and set a “neutral” rating for the company in a research note on Thursday, March 20th. Wells Fargo & Company decreased their target price on Omnicell from $49.00 to $40.00 and set an “equal weight” rating on the stock in a research report on Monday, January 13th. Benchmark restated a “buy” rating and issued a $62.00 price target on shares of Omnicell in a research report on Tuesday, February 4th. Finally, Bank of America decreased their price objective on shares of Omnicell from $54.00 to $46.00 and set a “neutral” rating on the stock in a research report on Monday, January 6th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $51.00.

Omnicell Stock Performance

NASDAQ OMCL opened at $30.95 on Thursday. The company has a quick ratio of 1.22, a current ratio of 1.37 and a debt-to-equity ratio of 0.13. The stock has a market cap of $1.45 billion, a price-to-earnings ratio of 114.63, a price-to-earnings-growth ratio of 7.53 and a beta of 0.78. Omnicell, Inc. has a fifty-two week low of $25.12 and a fifty-two week high of $55.75. The business has a fifty day moving average of $35.74 and a 200-day moving average of $41.45.

Omnicell (NASDAQ:OMCL) last announced its earnings results on Thursday, February 6th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.12). Omnicell had a net margin of 1.13% and a return on equity of 3.82%. As a group, analysts predict that Omnicell, Inc. will post 1.09 earnings per share for the current fiscal year.

Omnicell Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.